- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 35/28 - Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
Patent holdings for IPC class A61K 35/28
Total number of patents in this class: 5390
10-year publication summary
|
287
|
406
|
443
|
537
|
603
|
558
|
623
|
640
|
540
|
161
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 18943 |
99 |
| The Board of Trustees of the Leland Stanford Junior University | 6054 |
99 |
| Mesoblast International Sàrl | 132 |
91 |
| Children's Medical Center Corporation | 1780 |
81 |
| Mesoblast, Inc. | 68 |
49 |
| Samsung Life Public Welfare Foundation | 588 |
44 |
| SanBio, Inc. | 61 |
43 |
| The General Hospital Corporation | 4517 |
42 |
| President and Fellows of Harvard College | 5792 |
41 |
| Rohto Pharmaceutical Co., Ltd. | 349 |
31 |
| Sapporo Medical University | 141 |
31 |
| Tohoku University | 2526 |
31 |
| Sangamo Therapeutics, Inc. | 437 |
29 |
| FUJIFILM Corporation | 27102 |
28 |
| The Trustees of Columbia University in the City of New York | 3440 |
28 |
| Board of Regents, The University of Texas System | 5370 |
27 |
| ABT Holding Company | 109 |
27 |
| Minovia Therapeutics Ltd. | 47 |
27 |
| Osaka University | 3143 |
26 |
| Magenta Therapeutics, Inc. | 81 |
25 |
| Other owners | 4491 |